Abbott announced on Thursday the world’s first point-of-care viral load diagnostic test, has received the World Health Organization’s Prequalification approval (WHO PQ).
The recent discovery that an anti-HIV medication called dolutegravir can cause birth defects among pregnant women poses ethical challenges for doctors and patients in low-resource settings, according to reports.
Antiretroviral therapy (ART) is usually very effective at suppressing HIV in the body, allowing a person’s immune system to recover by preventing the virus from destroying CD4+ T cells(link is external).
Among people with HIV in Latin America, those diagnosed with tuberculosis (TB) at an initial clinic visit were about twice as likely to die within 10 years as people not initially diagnosed with TB, according to findings from a large observational study.
A clinical trial has begun to examine the safety and use of two HIV prevention tools – oral pre-exposure prophylaxis (PrEP) and a vaginal ring—in adolescent girls and young women in southern Africa.
The National Institutes of Health has awarded $7.5 million for an international research program to prevent and treat HIV infection among adolescents and young adults in seven African countries and Brazil.
An intervention designed to facilitate treatment for HIV and substance use was associated with a 50 percent reduction in mortality for people living with HIV who inject illicit drugs, a study has found.